高危早期非小细胞肺癌的肺叶切除替代方案
本文综述了对于肺储备受限、不适合肺叶切除的早期非小细胞肺癌患者,采用有限切除(亚肺叶切除)及非手术疗法(光子/质子立体定向放疗、射频消融、微波热消融)的结局与疗效证据,旨在为外科医生提供循证治疗菜单。
要点
- 肺叶切除仍是NSCLC外科治疗的标准。
- 肺储备受限者可考虑亚肺叶切除或非手术疗法。
- 综述评估了SBRT、射频消融和微波消融的疗效证据。
核心结论
- 对于不适合肺叶切除的高危早期NSCLC患者,应基于证据选择亚肺叶切除或非手术局部治疗。
研究设计与样本
- 综述评估有限切除及光子/质子立体定向放疗、射频消融、微波热消融的结局与疗效证据。
临床怎么用
- 为肺储备受限、非肺叶切除候选者的早期NSCLC患者提供循证治疗菜单。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The standard of care for the surgical management of non-small cell lung cancer remains a lobectomy. For patients with limited pulmonary reserve, lesser resections or nonoperative therapies may be indicated. The purpose of this review is to evaluate the outcomes from more limited resections as well as the evidence for the efficacy of photon-based and proton-based stereotactic body radiotherapy, radiofrequency ablation, and microwave thermal ablation. In doing so, the goal of this review is to provide surgeons with an evidence-based treatment menu for treating patients who are not candidates for lobectomy.
引用
- Klapper JA, Hittinger SA, Denlinger CE, et al. Alternatives to Lobectomy for High-Risk Patients With Early-Stage Non-Small Cell Lung Cancer. Ann Thorac Surg. 2017. PMID: 28359470. doi:10.1016/j.athoracsur.2016.11.045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。